TPC immunomodulates by stimulating colon anti-inflammatory cytokines (IL-10) and by downregulating pro-inflammatory cytokines (IL-1β, IL-17, and TNF-α) in collagen-induced arthritis model and DSS-induced colitis model [85,86]. This evidence concerns the gene IL17A and colitis.